Simulations Plus, Inc. (NASDAQ:SLP) Holdings Lowered by Bank of America Corp DE

Bank of America Corp DE trimmed its position in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 32.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,468 shares of the technology company's stock after selling 26,605 shares during the quarter. Bank of America Corp DE owned approximately 0.28% of Simulations Plus worth $1,547,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in SLP. Ameriprise Financial Inc. increased its position in Simulations Plus by 16.7% in the fourth quarter. Ameriprise Financial Inc. now owns 607,902 shares of the technology company's stock worth $16,954,000 after buying an additional 86,868 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Simulations Plus by 6.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 419,241 shares of the technology company's stock worth $11,693,000 after acquiring an additional 24,266 shares during the period. Royce & Associates LP increased its holdings in shares of Simulations Plus by 56.6% in the 4th quarter. Royce & Associates LP now owns 371,797 shares of the technology company's stock worth $10,369,000 after acquiring an additional 134,381 shares during the period. Kennedy Capital Management LLC lifted its position in Simulations Plus by 59.4% in the 4th quarter. Kennedy Capital Management LLC now owns 289,286 shares of the technology company's stock valued at $8,068,000 after purchasing an additional 107,766 shares during the last quarter. Finally, Northern Trust Corp boosted its stake in Simulations Plus by 10.0% during the 4th quarter. Northern Trust Corp now owns 236,373 shares of the technology company's stock valued at $6,592,000 after purchasing an additional 21,453 shares during the period. Institutional investors own 78.08% of the company's stock.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total transaction of $670,200.00. Following the completion of the sale, the director now directly owns 3,344,157 shares of the company's stock, valued at $112,062,701.07. This represents a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 19.40% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have commented on SLP. Wall Street Zen upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a research note on Monday, April 28th. KeyCorp increased their price objective on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday, April 16th. Finally, William Blair restated an "outperform" rating on shares of Simulations Plus in a research report on Tuesday. Two investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $50.00.

Simulations Plus Stock Performance

Shares of SLP stock traded down $0.24 during midday trading on Friday, reaching $27.55. 228,576 shares of the company were exchanged, compared to its average volume of 224,575. Simulations Plus, Inc. has a 12 month low of $23.01 and a 12 month high of $50.11. The company has a market cap of $554.06 million, a P/E ratio of 68.88 and a beta of 0.97. The company's 50 day moving average price is $30.63 and its two-hundred day moving average price is $30.37.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. The business had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business's revenue for the quarter was up 22.5% on a year-over-year basis. During the same quarter last year, the business earned $0.20 earnings per share. As a group, sell-side analysts predict that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.